TXMD - TherapeuticsMD Inc. (TXMD) CEO Rob Finizio on Q3 2021 Earnings Conference Call - Earnings Call Transcript

TherapeuticsMD, Inc. (TXMD) Q3 Earnings Conference Call November 11, 2021, 08:30 AM ET Company Participants Lisa Wilson – Investor Relations Rob Finizio – Chief Executive Officer Hugh O’Dowd – President James D'Arecca – Chief Financial Officer Mark Glickman – Chief Commercial Officer Conference Call Participants Louise Chen – Cantor Fitzgerald Annabel Samimy – Stifel Douglas Tsao – HC Wainwright Presentation Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD, Third Quarter 2021 Financial Results conference call. Following prepared remarks on the Company, we will open the call for questions. I would now like to turn the call over to Lisa Wilson, Investor Relations for TherapeuticsMD. Lisa. Lisa Wilson Thank you, operator. Good morning, everyone. And thank you for joining today to discuss our third quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our third quarter financial results. The press release

For further details see:

TherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q3 2021 Earnings Conference Call - Earnings Call Transcript